• RWD33 An Overview of Real-World Studies on Central Nervous System Diseases in China: A Decade of Data and Insights

    Jun 1, 2024, 00:00

  • EE249 Healthcare Utilization and Costs Associated with Remote Blood Pressure Monitoring in a US Integrated Healthcare System

    Jun 1, 2024, 00:00

  • SA37 Costs and Quality of Life in Clinical Trials of Heart Failure in the US

    Jun 1, 2024, 00:00

  • HTA Decisions and Deliberative Processes

    Jun 1, 2024, 00:00

  • EE170 Social and Clinical Factors Influencing ED Utilization Behavior Amongst Blue Cross Blue Shield of Louisiana Members: A Cluster Analysis

    Jun 1, 2024, 00:00

  • EE312 Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) in Pregnant Individuals for the Prevention of Respiratory Tract Disease (RTD) Caused by RSV Among Infants in Canada

    Jun 1, 2024, 00:00

  • EE115 Clinical and Economic Impact of Glucagon-like Peptide-1 Agonists in Patients with Obstructive Sleep Apnea: An Exploratory Analysis

    Jun 1, 2024, 00:00

  • SA11 Real-World Effectiveness and Safety of First-Line Pembrolizumab Monotherapy for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • EPH87 Invasive Meningococcal Disease Risk Factors in Individuals With Commercial and Medicare Insurance in the United States

    Jun 1, 2024, 00:00

  • EE13 Cost-Effectiveness Analysis of Duodenal–Jejunal Bypass Sleeve Device for People With Obesity

    Jun 1, 2024, 00:00

  • EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis

    Jun 1, 2024, 00:00

  • EE499 Economic Burden of Prescription Opioid Abuse in the United States: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HSD64 Data Visualization of Patterns of Adjuvant Endocrine Therapy Among Older Women With Hormone-Positive Early-Stage Breast Cancer

    Jun 1, 2024, 00:00

  • MT20 Validation of the Sensal Health Smart Dock TM Medication Adherence Device

    Jun 1, 2024, 00:00

  • PCR225 The Caregiver Perspective on Dry Age-Related Macular Degeneration: A Qualitative Interview Study

    Jun 1, 2024, 00:00

  • HPR10 Cell and Gene Therapy Access in the US and European Countries

    Jun 1, 2024, 00:00

  • Reviewer Acknowledgment

    Jun 1, 2024, 00:00

  • HPR11 Revenue-Sharing or Revenue Lost? The Hidden Costs of 340B to Employers

    Jun 1, 2024, 00:00

  • PCR171 Measuring Disease and Treatment-Related Symptoms and HRQoL Impacts in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) Using the EORTC Qlq-C30 and NMIBC-24: Qualitative Literature Review and Gap Analysis

    Jun 1, 2024, 00:00

  • MSR67 Modelling the Patient-Level Dependence of Overall Survival on Time to Objective Response in Oncology Studies Using Copulas

    Jun 1, 2024, 00:00

  • HPR22 Does Expedited Regulatory Approval Status Increase Rare Disease Drug Non-Coverage?

    Jun 1, 2024, 00:00

  • PCR29 Patient and Caregiver Perspectives Regarding Once-Weekly Injection Devices in Growth Hormone Deficiency: Qualitative Interviews To Inform a Patient Preference Study

    Jun 1, 2024, 00:00

  • RWD63 Utilizing AI/ML for Insight Into the Transition Factors From Traditional (Non-Nano Delivery) to Nano Drug Delivery of Paclitaxel in Breast Cancer Patients

    Jun 1, 2024, 00:00

  • EE354 Economic Burden of ICU Diseases and Injuries in Brazil During the COVID-19 Pandemic

    Jun 1, 2024, 00:00

  • RWD38 The Use of Patient-Generated Functional Outcome Measures in Trials Seeking to Show Improvements in Negative Symptoms or Cognitive Impairment Associated with Schizophrenia

    Jun 1, 2024, 00:00

  • EE27 Cost-Effectiveness of Chondroitin Sulfate Plus Glucosamine Versus Celecoxib for Moderate To Severe Knee Osteoarthritis

    Jun 1, 2024, 00:00

  • SA62 Treatment Patterns Following First Line CDK4/6 Inhibitor Progression in HR+, HER2- Metastatic Breast Cancer

    Jun 1, 2024, 00:00

  • MSR62 Clinical Validation of an N-Gram Model for Detecting Economic Insecurity in Patient Populations Using Unstructured Clinical Notes

    Jun 1, 2024, 00:00

  • RWD186 Economic Evaluation of Biosimilar Market in the US: Insights From a Real-World Analysis Using De-Identified Market Clarity Database

    Jun 1, 2024, 00:00

  • HSD4 First-Generation Antipsychotic Shortages in the United States: Analysis of Switching and Utilization Patterns

    Jun 1, 2024, 00:00

  • EE113 Impact of Type 1 Diabetes and Severe Hypoglycemia on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • EE29 Cost-Effectiveness of Niraparib Plus Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer

    Jun 1, 2024, 00:00

  • MSR73 Lessons Learned from Confounder Identification: Insights from German HTA Procedures

    Jun 1, 2024, 00:00

  • HSD125 Second-Line Antidiabetic Agent Order Patterns in Patients With Type 2 Diabetes Across Healthplan Types

    Jun 1, 2024, 00:00

  • EPH38 Antimicrobial Susceptibility of Klebsiella Pneumoniae Clinical Isolates From the Lower Respiratory Tract Infection During the COVID-19 Pandemic in Brazil (SMART 2020-2021)

    Jun 1, 2024, 00:00

  • EE55 Medico-Economic Contribution of Multiplex PCR To the Diagnosis of Meningitis

    Jun 1, 2024, 00:00

  • SA43 Potential for Drug Development Using Artificial Intelligence and Machine Learning

    Jun 1, 2024, 00:00

  • EE321 Budget Impact Model for Dasiglucagon in the Prevention and Treatment of Hypoglycemia in Pediatric Patients with Congenital Hyperinsulinism in the United States

    Jun 1, 2024, 00:00

  • EE479 Adverse Event Costs Associated With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States, Italy, Portugal, and Spain

    Jun 1, 2024, 00:00

  • HSD76 A Systematic Literature Review (SLR) to Evaluate the Role of Socioeconomic Factors Associated with Treatment Practices Among Oncology Patients

    Jun 1, 2024, 00:00

  • PCR97 Consequences of Misdiagnosed Opsoclonus Myoclonus Ataxia Syndrome (OMAS)

    Jun 1, 2024, 00:00

  • EE242 Economic and Clinical Impact of Cost-Effective Kidney-Related Healthcare Interventions to Manage the Burden of CKD in the UK: Estimates for the Next 10 Years (2023 to 2033)

    Jun 1, 2024, 00:00

  • PCR89 Impact of Dosing and Administration on HRQoL Among People With Hemophilia: A Time Trade-Off Study Including 2.250 Respondents in the UK, Canada and the US

    Jun 1, 2024, 00:00

  • RWD121 Mental Health Outcomes and Treatments Utilized for Postpartum Depression Patients Hospitalized for a Mood Disorder in the US Using Real-World Data

    Jun 1, 2024, 00:00

  • CO21 Association between Pregnant Cigarette Smoking and Offspring Birthweight Using Oracle EHR Real-World Data

    Jun 1, 2024, 00:00

  • PCR26 Impact of Attention-Deficit/Hyperactivity Disorder Treatment Adverse Effects on Quality of Life and Functioning of Pediatric Patients and Their Parents/Caregivers

    Jun 1, 2024, 00:00

  • MSR47 Assessing the Impact of the Prior Distribution for the Within-Study Correlation in Bivariate Network Meta-Analysis: A Case Study in Relapsed/Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • EE21 Healthcare Resource Utilization Comparison of Balloon-Expandable Valve Versus Self-Expandable Valve for Transcatheter Aortic Valve Replacement in China

    Jun 1, 2024, 00:00

  • EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments

    Jun 1, 2024, 00:00

  • PCR145 Using Survey Data and Qualitative Interviews to Support Content Validity for Spinocerebellar Ataxia (SCA) Patients

    Jun 1, 2024, 00:00

  • EPH165 The Fiscal Costs of a Public Health Crisis: Lessons From Zika in the United States

    Jun 1, 2024, 00:00

  • HSD122 Medication Adherence, Persistence, and Treatment Switching in Patients Receiving Advanced Therapies for Rheumatoid Arthritis in Clinical Practice

    Jun 1, 2024, 00:00

  • RWD22 Utilizing Optum® Market Clarity Dataset for Analyzing Treatment Patterns and Clinical Outcomes in Diabetes: A Propensity Score Matched Study Comparing Gender Cohorts

    Jun 1, 2024, 00:00

  • EE438 A Budget Impact Model (BIM) for the Introduction of the TEARCARE® System to a United States (US) Health Plan for the Treatment of Meibomian Gland Dysfunction (MGD)-Associated Dry Eye Disease (DED)

    Jun 1, 2024, 00:00

  • EE324 Describing the Clinical and Economic Burden of Women Diagnosed With Uterine Fibroid (UF) and Heavy Menstrual Bleeding (HMB) in a United States (US) Commercial Database 2015-2022

    Jun 1, 2024, 00:00

  • EPH173 Estimating the Utilization of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) and the Impact on Syphilis Rates in Colorado

    Jun 1, 2024, 00:00

  • EPH46 Prognostic and Risk Factors of Psoriatic Arthritis Among Adult Psoriasis Patients in the United States: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HPR59 Do All US Payer Archetypes Consider the Same Sources of Evidence to Inform Their Drug Policies?

    Jun 1, 2024, 00:00

  • CO156 Indirect Treatment Comparison (ITC) of Cabotegravir Long Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Versus No Prep for HIV Prevention

    Jun 1, 2024, 00:00

  • HTA54 AMNOG Benefit Assessment in Germany: Outcomes from 2011 to November 2023

    Jun 1, 2024, 00:00

  • MSR55 Predictive Horizons: Unveiling Cardiovascular Insights With Conditional Inference Trees

    Jun 1, 2024, 00:00

  • EE42 Value of Being the First Biosimilar Entrant

    Jun 1, 2024, 00:00

  • CO105 Disease Burden and Treatment in Patients with Essential Tremor in the United States: Real-World Evidence from a Cross-Sectional Survey of Physicians and Patients

    Jun 1, 2024, 00:00

  • RWD168 Fractures in Adults Age Eighty and Older in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • P54 Evaluating ChatGPT's Efficacy and Efficiency in the Risk of Bias Assessment in Health Economic Evaluations: A Comparative Analysis Using the Drummond Checklist

    Jun 1, 2024, 00:00

  • EE23 Evaluation of the Relative Impact of Factors Influencing Originator U.S. Market Share Following Biosimilar Launch

    Jun 1, 2024, 00:00

  • EE46 An Early Cost-Effectiveness Analysis of Abelacimab Versus Rivaroxaban, a Standard of Care Direct Oral Anticoagulant (DOAC), in Patients with Atrial Fibrillation Using Preliminary Results from the AZALEA-TIMI 71 Trial

    Jun 1, 2024, 00:00

  • Economic Impact of Rare Diseases

    Jun 1, 2024, 00:00

  • EE241 JAV-RARAS: Microscopic Analysis of Patients with Familial Amyloidotic Polyneuropathy in Brazil

    Jun 1, 2024, 00:00

  • RWD159 Assessing the Relationship between Initial Opioid Prescription and Subsequent Pain-Related Healthcare Resource Utilization and Costs Among Patients with Chronic Pain

    Jun 1, 2024, 00:00

  • EE71 Understanding Pharmacy Costs and the Changing Treatment Landscape in Huntington's Disease (HD) in the US: A Systematic Literature Review (SLR) and Database Review for Disease-Modifying Therapies (DMT) in Development

    Jun 1, 2024, 00:00

  • RWD109 The Impact of the out-of-Pocket Cost of Insulin on Healthcare Resource Utilization and All Healthcare-Related Costs Using the Medical Expenditure Panel Survey 2016-2018

    Jun 1, 2024, 00:00

  • CO17 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Immuno-Oncology (IO) for First-Line (1L) Esophageal Squamous Cell Carcinoma (ESCC) in Adult Patients

    Jun 1, 2024, 00:00

  • EE389 Economic Burden of Diagnosed Congenital Cytomegalovirus in the United States and Japan

    Jun 1, 2024, 00:00

  • CO136 Unmet Treatment Needs in the Management of Patients With Eosinophilic Esophagitis: Insights From a Real-world Survey

    Jun 1, 2024, 00:00

  • PCR179 Manifestations and Comorbid Conditions Among Patients with Osteogenesis Imperfecta (OI): A US Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • EE125 Evaluating the Impact of Hybrid Closed-Loop Systems (HCLS) on Healthcare Utilization and Costs Compared to Standard of Care Therapy Among Patients with Type 1 Diabetes New to Pump Therapy

    Jun 1, 2024, 00:00

  • RWD64 Comorbidities of Irritable Bowel Syndrome in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE351 Economic Evaluation of Botulinum Toxin Type a (XEOMEEN) in the Treatment of Adult Patients With Spasticity in the "IMSS” and “ISSSTE”

    Jun 1, 2024, 00:00

  • Award Winners

    Jun 1, 2024, 00:00

  • CO184 A Matching-Adjusted Indirect Comparison of Centanafadine Vs Lisdexamfetamine, Methylphenidate, and Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: Long-Term Safety and Efficacy Outcomes

    Jun 1, 2024, 00:00

  • HTA45 Comparison of the Use of Real-World Evidence for Clinical Effectiveness in HTA Pre- and Post- Introduction of the NICE Framework – an Update

    Jun 1, 2024, 00:00

  • EPH80 Outpatient Transfusions and Occurrence of Febrile Non-Hemolytic Transfusion Reactions Among U.S. Medicare Beneficiaries, Ages 65 and Older, During 2016-2022: Utility of Real-World Data

    Jun 1, 2024, 00:00

  • RWD18 Healthcare Costs Associated With Type 1 Diabetes in Adults With a Commercial, Medicaid, or Medicare Coverage in US Clinical Practice

    Jun 1, 2024, 00:00

  • EPH200 Epidemiological Disease Burden of Female Infertility Associated with Male Factors Based on Routinely Collected Health Data between 2010-2019

    Jun 1, 2024, 00:00

  • HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023

    Jun 1, 2024, 00:00

  • EE327 Public Preferences for Improving Health Equity: A Qualitative Focus Group Study

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • CO12 A Review of Goal Attainment Scaling Implementation As a Personalized Clinical Outcome Assessment over the Last Decade

    Jun 1, 2024, 00:00

  • HPR124 Is Obesity a Disease or a Lifestyle Issue in Europe and the United States? Payer Perception

    Jun 1, 2024, 00:00

  • P26 Analyzing Drug Shortages and Pricing: Lessons from Canada

    Jun 1, 2024, 00:00

  • CO107 Assessing Short and Long-Term Outcomes in Drug-Associated Acute Kidney Injury

    Jun 1, 2024, 00:00

  • HTA17 Cost-Effectiveness Analysis of Capivasertib Plus Fulvestrant in Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2-) Negative Advanced Breast Cancer: A US Payer Perspective

    Jun 1, 2024, 00:00

  • EPH40 Changing Role of Comorbidities in Risk of Mortality Among Elderly Patients Diagnosed with COVID-19 in the United States: Examining Pre- and Post-Vaccine Clinical Risk Factors

    Jun 1, 2024, 00:00

  • EE487 Exploring the Healthcare Resource Utilization (HCRU) Associated with Rare Diseases (RD) in the United States (US): A Systematic Literature Review (SLR) across Six Disease Areas

    Jun 1, 2024, 00:00

  • HPR3 Exploring the Inequity of HRQoL in Individuals With Long COVID Symptoms

    Jun 1, 2024, 00:00

  • EE482 Building Better Models: A Simulation Case Study Demonstrating the Crucial Role of Ergodicity in Building Robust Markov Chains

    Jun 1, 2024, 00:00

  • MSR33 Health State Transition Probabilities for Duchenne Muscular Dystrophy: Estimation from Published Data

    Jun 1, 2024, 00:00

  • HPR102 Trends in Specialty Pharmacy Use Among US Medicare Beneficiaries: Implications for Part D Policy

    Jun 1, 2024, 00:00

  • CO197 Vaso-Occlusion Definitions Can Impact Efficacy Assessments in Clinical Studies of Sickle Cell Disease

    Jun 1, 2024, 00:00

  • PCR124 Burden of Fracture and Fracture Management Among Individuals with Osteogenesis Imperfecta: Results from a Survey of Adults and Caregivers

    Jun 1, 2024, 00:00

  • HPR5 National US Health Equity Survey Demonstrates Some Progress on Organizational Health Equity Goals, Emerging Priorities on Activation, Analytics, and Capacity Building

    Jun 1, 2024, 00:00

  • Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues

    Jun 1, 2024, 00:00

  • HSD128 Opioid Utilization in Rheumatoid Arthritis: Changes in Opioid Use after Advanced Therapy Initiation and Its Moderators

    Jun 1, 2024, 00:00

  • PT34 Assessment of Direct, Indirect, and Intangible Costs of Rheumatoid Arthritis in Patients Receiving Biological Therapy in Morocco: Ecoram Study

    Jun 1, 2024, 00:00

  • RWD43 The Use of Code Llama, a Large Language Model, as Programming Assistant in Real-World Research

    Jun 1, 2024, 00:00

  • PCR250 Need for Care in Essential Tremor and the Indirect Burden on Care Partners

    Jun 1, 2024, 00:00

  • PCR201 Understanding the Patient Experience With High Cholesterol in the United States: A Patient-Community-Led Qualitative Study

    Jun 1, 2024, 00:00

  • EE28 Value of Knowing Risk of Developing Neurodegenerative Disease: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • EE525 Comparative Analysis of Launch Prices for Orphan Drugs in the US and EU4

    Jun 1, 2024, 00:00

  • EPH135 Impact of Demographics and Social Determinants of Health on Hospitalization Costs in US Adults With Respiratory Syncytial Virus

    Jun 1, 2024, 00:00

  • HSD65 Influence of Research Findings and Systems on Minimal Residual Disease (MRD) Testing and FLT3 Inhibitor Maintenance Prescribing Behavior Post-Transplant for Patients with Acute Myeloid Leukemia (AML) of U.S. Oncologists

    Jun 1, 2024, 00:00

  • RWD174 Health Care Resources Associated with Clinical Pneumonia, Bacteremia or Meningitis in Colombian Adults: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • HSD111 Socio-Economic and Foeto-Maternal Characteristics of Home Childbirth in 12 African Countries: A Multinational Survey Using the Most Recent Demographic and Health Survey (DHS) Data

    Jun 1, 2024, 00:00

  • CO150 Efficiacy of Back School Program in Connection with Physical Activity Amongst Hungarian Adolescents

    Jun 1, 2024, 00:00

  • EE266 The Economics Promises of a Cure: Best Practices to Guide Economic Negotiations for the Reimbursement of Curative Therapies for Cancer

    Jun 1, 2024, 00:00

  • RWD172 Healthcare Utilization and Costs Among Patients With Episodic Migraine Initiating Galcanezumab Versus Rimegepant for Migraine Prevention in the United States

    Jun 1, 2024, 00:00

  • EE240 Economic Impact of Direct Costs Associated with Stroke in Patients with Type 2 Diabetes from the Perspective of the Social Security and Private Healthcare Providers in Argentina

    Jun 1, 2024, 00:00

  • MSR103 Optimizing Systematic Literature Reviews in Endometrial Cancer: Leveraging AI for Real-Time Article Screening and Data Extraction in Clinical Trials

    Jun 1, 2024, 00:00

  • MSR84 Understanding How Baseline Risk Affects Treatment Outcomes in Clinical Trials: Exploring Key Factors

    Jun 1, 2024, 00:00

  • EE442 Impact of Benralizumab on Asthma and COPD Exacerbation-Related Healthcare Resource Utilization in Patients with Asthma and Concomitant COPD

    Jun 1, 2024, 00:00

  • MSR50 Machine Learning Models for Predicting Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the General United States Population

    Jun 1, 2024, 00:00

  • EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective

    Jun 1, 2024, 00:00

  • CO95 Growing Acceptance of Minimal Residual Disease (MRD) As a Primary Endpoint in Multiple Myeloma (MM) Clinical Trials

    Jun 1, 2024, 00:00

  • MSR102 Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis Comparing Binomial and Multinomial Approaches

    Jun 1, 2024, 00:00

  • EE50 Estimating the Clinical and Economic Outcomes of Universal Varicella and Herpes Zoster Vaccination in Belgium Using a Dynamic Transmission Model With Dynamic Population

    Jun 1, 2024, 00:00

  • PCR136 Development of a Patient Preference Questionnaire Appropriate for Use with Potential Regimens for HIV Cure

    Jun 1, 2024, 00:00

  • CO187 Acute Pancreatitis Risk Associated with Glucagon-Like Peptide-1 Receptor Agonists Used for Weight Loss: A Retrospective Cohort Study in the United States

    Jun 1, 2024, 00:00

  • MSR54 Estimating Drinking Trajectories in the United States From Adolescence to Old Age: A Three-Step Approach

    Jun 1, 2024, 00:00

  • P58 Clinical Impact of Replacing 13-Valent With a 15-Valent Pneumococcal Conjugate Vaccine in Costa Rican National Immunization Program

    Jun 1, 2024, 00:00

  • P28 Impact of FDA Expedited Review Programs on New Drug Approval Time

    Jun 1, 2024, 00:00

  • PCR218 Gender Is Not Binary: An Online Survey To Improve Inclusivity in Sex and Gender Demographic Questions

    Jun 1, 2024, 00:00

  • CO211 Gout Epidemiology, Pharmacotherapy, Healthcare Utilization, and Outcomes for United States Veterans Affairs Patients From 2016 to 2022

    Jun 1, 2024, 00:00

  • EPH221 Stigma As a Barrier to Treatment: Evidence from the National Health and Wellness Survey

    Jun 1, 2024, 00:00

  • EPH74 Incidence and Lethality of Adult Pneumonia, Bacteremia, or Meningitis in Colombia From 2015 to 2022: A Retrospective, Database Study

    Jun 1, 2024, 00:00

  • PCR211 Health-Related Quality of Life in Adult Patients With Glaucoma, With or Without Visual Impairment in the US: Analysis of National Data From 2017 to 2021

    Jun 1, 2024, 00:00

  • EE195 The Cost of Missing Physiotherapy Appointments

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • HPR131 The Risk of Osteoporotic Fractures in Elderly Asthmatic Patients According to Prescribing Patterns of Systemic Corticosteroid in South Korea

    Jun 1, 2024, 00:00

  • Disclosure Information

    Jun 1, 2024, 00:00

  • OP13 A Descriptive Analysis of Key Findings from the 2023-24 ISPOR Student Interest Survey

    Jun 1, 2024, 00:00

  • EE322 Addressing Decision Uncertainty in a Cost-Effectiveness Model of Opioid Use Disorder Treatments: Estimating the Value of Information and the Sample Size to Provide It

    Jun 1, 2024, 00:00

  • MT25 Smartphone-Acquired Patient Reported Outcomes and Wrist-Worn Wearable Device-Acquired Sensing Data in Rheumatoid Arthritis: A Multicenter Single-Arm Prospective Study for Digital Biomarker (INTERIM REPORT)

    Jun 1, 2024, 00:00

  • MSR24 A Case Study Using Keynote-010 to Compare and Evaluate Long-Term Survival Estimates from Two Classes of Piecewise Models

    Jun 1, 2024, 00:00

  • CO153 Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

    Jun 1, 2024, 00:00

  • CO182 Intelligence Quotient (IQ) Scores Among Early-Treated Phenylketonuria (PKU) Patients: Results from a Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • HTA3 What Are the Reasons for Receiving a Negative Decision from NICE? - A 5-Year Review (2019-2023) of NICE Decisions

    Jun 1, 2024, 00:00

  • CO73 Clinical Significance of KL-6 Biomarker in the Development of Connective Tissue Disease-Associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • RWD117 Unraveling Disparities in Right Heart Failure: A Comprehensive Analysis of Demographics, Socioeconomic Factors, and Mortality Predictors in a 117,633-Patient Cohort (2017-2020)

    Jun 1, 2024, 00:00

  • EE24 Analysis of out-of Pocket Payment Associated to Female Infertility in Hungary between 2015-2022

    Jun 1, 2024, 00:00

  • PCR142 Qualitative Insights Into Disease Burden and Meaningful Change Associated With Cutaneous Neurofibromas (CNFs) in Adults With Neurofibromatosis Type 1

    Jun 1, 2024, 00:00

  • EE112 Baricitinib in Alopecia Areata: A Budget Impact Analysis in Saudi Setting

    Jun 1, 2024, 00:00

  • EPH44 Healthcare Expenditures Among Older Adult with Polypharmacy in the United States: A Propensity Score-Matched Cross-Sectional Study

    Jun 1, 2024, 00:00

  • CO145 Incidence of Acute Exacerbations Among Patients With Fibrotic Interstitial Lung Disease in the United States

    Jun 1, 2024, 00:00

  • HPR62 Analysis of FDA-Issued Warning Letters for Fraudulent Claims Within the Economic, Clinical, and Humanistic Outcomes (ECHO) Framework

    Jun 1, 2024, 00:00

  • Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review [Editor's Choice]

    Jun 1, 2024, 00:00

  • EE376 The Budget Impact of Introducing Multiparametric MRI (mpMRI) As a Monitoring Tool to Identify Non-Responders Undergoing Thyroid Hormone Receptor Treatment for MASH

    Jun 1, 2024, 00:00

  • CO125 Disease Burden of Epithelial Ovarian Cancer in Chinese Patients Under Current Care: A Model Simulation Study

    Jun 1, 2024, 00:00

  • OP1 Assessing the Quality and Impact of Patient Engagement: Co-Creation of the Patient Engagement Impact Measurement (PEIM) Framework and Metrics

    Jun 1, 2024, 00:00

  • HSD27 Patterns of Postoperative Opioid Dispensing for Common Surgical Procedures Among Medicaid Beneficiaries in 2020-2021

    Jun 1, 2024, 00:00

  • Methodological Statistical Research

    Jun 1, 2024, 00:00

  • PCR104 The Self-Management Activities, Health Literacy and Health-Related Quality of Life of Patients with Type 2 Diabetes: A Structural Equation Modelling in Vietnam

    Jun 1, 2024, 00:00

  • RWD107 Gender Disparities in the Management of Rheumatoid Arthritis in the US: A Real-World Evidence Study

    Jun 1, 2024, 00:00

  • CO138 Impact of Steroid Withdrawal at Various Time Points After Liver Transplantation on Diabetes Mellitus: A Population-Based Cohort Study in South Korea

    Jun 1, 2024, 00:00

  • EPH206 Incidence and Risk Factors for Empiric Treatment Failure Among Females With Uncomplicated Urinary Tract Infections in an Integrated Health Delivery Network

    Jun 1, 2024, 00:00

  • P43 Cost-Effectiveness of Talquetamab-tgvs Vs Idecabtagene Vicleucel for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • MSR98 Prediction of Antipsychotic Associated Weight Gain in Children and Adolescents Taking Second Generation Antipsychotics: A Machine Learning Approach

    Jun 1, 2024, 00:00

  • EPH30 Real-World Adherence to Glycemic Self-Monitoring and Associated Factors Among Type 2 Diabetes Patients in Algeria: A Descriptive Cross-Sectional Study

    Jun 1, 2024, 00:00

  • MSR97 Indirect Estimation of Post-Distant Recurrence Survival (PDRS) for Resected Stage II/III Melanoma: A Network-Meta Analysis (NMA) Approach

    Jun 1, 2024, 00:00

  • EE139 Intensification with Insulin Glargine 300 U/Ml (Gla-300) or First- Generation Basal Insulins (BIs) in People with Type 2 Diabetes (T2D) on Once-Weekly Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): Deliver New-G

    Jun 1, 2024, 00:00

  • EPH129 Tobacco Product Experien Which Consumer Reported Outcome Measures for Real World Evidence Studies?

    Jun 1, 2024, 00:00

  • PT27 Changes in the Economic Burden of Breast Cancer Neoplasms in Colombia After the Cancer Control Model

    Jun 1, 2024, 00:00

  • SA60 The Use of Natural Language Processing in Literature Reviews

    Jun 1, 2024, 00:00

  • EPH204 Chronic Liver Disease Is Associated with Greater Risk of Hospital Readmission in Patients with Heart Failure: A Nationwide Database Study in the US

    Jun 1, 2024, 00:00

  • EE478 Willingness to Pay Study for Migraine Medications in Argentina

    Jun 1, 2024, 00:00

  • EE2 Challenges of Evaluating and Modelling Vaccination for Prevention of Dengue Illness in United Kingdom (UK) Travelers: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EE329 Budget Impact of Low-Dose Computed Tomography Screening for Lung Cancer in Argentina

    Jun 1, 2024, 00:00

  • CO54 Timely Rheumatoid Arthritis Control With Biologic or Targeted Synthetic DMARDs in Clinical Practi Separating Successes From Opportunities for Care Improvement

    Jun 1, 2024, 00:00

  • EPH231 HPV Genotyping in Invasive Cervical Cancer Samples from Women Attended at an Oncological Hospital between 2017-2021 in Ecuador

    Jun 1, 2024, 00:00

  • EE66 Cost-Effectiveness Analysis of Pembrolizumab + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer in Japan

    Jun 1, 2024, 00:00

  • PCR197 Health-related Quality of Life (HRQoL) Among Patients Who Have Survived an Episode of Sepsis in the United States: A Systematic Review

    Jun 1, 2024, 00:00

  • EE474 Value Assessment Under Uncertainty: Measuring Insurance Value and Risk Aversion for a Novel Neurological Treatment Using a Stated Preference Survey

    Jun 1, 2024, 00:00

  • EE506 Clinical Consequences and Associated Costs of Treating Patients With Waldenström Macroglobulinemia in the First-Line Setting With Bruton Tyrosine Kinase Inhibitors

    Jun 1, 2024, 00:00

  • CO169 Ensifentrine, an Investigational, Inhaled PDE3/4 Inhibitor, Decreased COPD-Related Healthcare Resource Utilization over 24 Weeks

    Jun 1, 2024, 00:00

  • EE415 Cost of Hypoglycemia Among Hospitalized Patients With Diabetes Mellitus

    Jun 1, 2024, 00:00

  • RWD68 The TriNetX Linked EHR and Administrative Claims Network

    Jun 1, 2024, 00:00

  • CO123 Socio-Demographics, Clinical Characteristics, and Quality of Life in Patients with Parkinson’s Disease with and without Comorbid Insomnia

    Jun 1, 2024, 00:00

  • AI and Machine Learning in HEOR

    Jun 1, 2024, 00:00

  • EPH81 Patient Characteristics and Health Care Resource Utilization of Cognitive Impairment Among Patients with Schizophrenia in the Veterans Affairs Administration System

    Jun 1, 2024, 00:00

  • EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction

    Jun 1, 2024, 00:00

  • EPH9 Safety Assessment of Nirmatrelvir-Ritonavir in the FDA Adverse Event Reporting System: A Data Mining Approach

    Jun 1, 2024, 00:00

  • PCR221 Sunbathing Habits, Knowledge A Level, and Sun Protection Related to Skin Cancers Among Adults

    Jun 1, 2024, 00:00

  • EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador

    Jun 1, 2024, 00:00

  • MSR69 Systematic Review and Meta-Analysis of Fecal Incontinence Prevalence and Population Estimates

    Jun 1, 2024, 00:00

  • PCR58 Subjective Expectations on Having Implanted Medical Devices at Older Ages: Results of a Cross-Sectional Population Survey

    Jun 1, 2024, 00:00

  • CO66 Optimizing GPT-4 Prompts for Population Eligibility Screening in COA Landscape Reviews of Qualitative Studies

    Jun 1, 2024, 00:00

  • EE341 A Comparison of Stapling Costs Used in Hybrid vs Robotic Surgery

    Jun 1, 2024, 00:00

  • HPR4 What Makes an Orphan Medicine? Determining Characteristics of Non-Oncology Orphan Approvals from 2015-2022

    Jun 1, 2024, 00:00

  • PCR156 The Balancing Act of Paid Work and Caregiving in Duchenne Muscular Dystrophy (DMD): Results From a Cross-Sectional Survey

    Jun 1, 2024, 00:00

  • HSD81 Impact of Specialty Pharmacy: A Study in Inflammatory Conditions

    Jun 1, 2024, 00:00

  • PCR154 Health State Utility Values in COVID-19: A Vignette Study in Japan

    Jun 1, 2024, 00:00

  • P12 Racial and Ethnic Fairness in Risk Prediction Models for Cardiovascular Diseases Among U.S. Adults

    Jun 1, 2024, 00:00

  • CO114 Clinical Characteristics, Diagnosis, and Impact on Employment in Patients With Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Canada

    Jun 1, 2024, 00:00

  • EPH168 Incidence of Pre-Dialysis Depression and Its Impact on Chronic Kidney Disease (CKD) Progression

    Jun 1, 2024, 00:00

  • EPH45 Survey of Residents’ Perceptions and Concerns on Air Pollution in Maharashtra, India

    Jun 1, 2024, 00:00

  • CO39 Influence of Socioeconomic Status on Breast Cancer Treatment in the US: Preliminary Results from a Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE155 Budget Impact Analysis: Alteplase for Stroke Treatment in Argentina

    Jun 1, 2024, 00:00

  • EE475 The Benefit-Cost Analysis Adjustment Through the Generalized Risk-Adjustment Cost-Effectiveness (GRACE) Framework: An Application on Acute Ischemic Stroke Patients

    Jun 1, 2024, 00:00

  • MSR29 Application of a Novel Bayesian Dynamic Borrowing Approach Using Anonymized Finnish Real-World Data As an External Control Arm to Augment an Internal Control Arm of a Randomized Clinical Trial

    Jun 1, 2024, 00:00

  • HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey

    Jun 1, 2024, 00:00

  • EPH84 Relationship between the Effectiveness of Municipal Public Health Plans and Programs for the Prevention of Suicide and Suicide Attempts with Their Operational and Financial Performance

    Jun 1, 2024, 00:00

  • MSR66 Development and Validation of Risk Prediction Tools for Pressure Injury Occurren An Umbrella Review

    Jun 1, 2024, 00:00

  • CO121 Evaluating Disparities in Clinical Outcomes Among Medicare Beneficiaries With Peripheral Artery Disease (PAD): A Call To Action for Health Equity

    Jun 1, 2024, 00:00

  • EE417 Healthcare Resource Use and Costs of Care in HR+/HER2- Metastatic Breast Cancer: A Retrospective US Claims Data Study

    Jun 1, 2024, 00:00

  • PCR253 Knowledge, Attitude, and Practices (KAP) Regarding Vaccination Against Human Papillomavirus (HPV) Among Young People, Caregivers, and Healthcare Professionals (HCPs)

    Jun 1, 2024, 00:00

  • RWD162 The Development of a National Standardset for Bariatric Surgery Followed By a Digital Solution to Scale It at a National Level in Portugal

    Jun 1, 2024, 00:00

  • MT32 Novel Graft Materials for Lumbar Spinal Fusion Procedures:12 Months Outcomes

    Jun 1, 2024, 00:00

  • The Patient and Caregiver Perspective for Healthcare Decision-Making

    Jun 1, 2024, 00:00

  • SA47 A Systematic Literature Review and Pooled Rates Analysis of Heart Failure Trials in the US

    Jun 1, 2024, 00:00

  • EE187 Remdesivir Reduced Healthcare Resource Utilization in Patients Hospitalized With COVID-19 During the Omicron-Dominant Period

    Jun 1, 2024, 00:00

  • PT26 Health Economic Impact of Non-Persistence with Tamoxifen Adjuvant Endocrine Therapy in Pre-Menopausal Women with Early-Stage Breast Cancer: A Simulation Study

    Jun 1, 2024, 00:00

  • RWD143 Update of Our Review of Real-World Evidence in HTA Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan

    Jun 1, 2024, 00:00

  • HTA55 USA Vs. Global Pharmaceutical Launches: What Are the Potential Reasons That Can Result in a Pharmaceutical Not Being Commercialized Outside the USA?

    Jun 1, 2024, 00:00

  • RWD85 An Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

    Jun 1, 2024, 00:00

  • EE334 The Diagnostic Odyssey and Cost-Effectiveness of Genomic Testing in Indigenous Children in British Columbia, Canada

    Jun 1, 2024, 00:00

  • CO55 Incidence of Adverse Events with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review of Literature

    Jun 1, 2024, 00:00

  • HTA80 Impact of Restricted EU Market Access Decisions on Patient Access To Medicines in Multiple Myeloma

    Jun 1, 2024, 00:00

  • PCR255 Evaluating the Suitability of Patients As Proxies for Caregivers’ HR-QoL Assessments

    Jun 1, 2024, 00:00

  • EE194 Health Care Resource Utilization, Total and out of Pocket Expenditures Among Adults with Rheumatoid Arthritis: Medical Expenditure Panel Survey Study

    Jun 1, 2024, 00:00

  • RWD28 Adherence to Janus Kinase Inhibitors Among Older Adults with Rheumatoid Arthritis Initiating New Treatment

    Jun 1, 2024, 00:00

  • EE69 Estimating a Drug's Price After Loss of Exclusivity As a Function of the Cost of Goods Sold

    Jun 1, 2024, 00:00

  • MSR78 The Impact of Variable Days of Coverage on Estimating Diagnosis and Treatment Prevalence From Administrative Claims Data

    Jun 1, 2024, 00:00

  • PT5 Impacts of National Drug Price Negotiation on Type 2 Diabetes Drugs Price, Volume, and Spending in China

    Jun 1, 2024, 00:00

  • EE156 Temporal Excess Hospital Costs of Complications in Chinese Patients With Type 2 Diabetes: Results from the Joint Asia Diabetes Evaluation (JADE) Register (2007-2018)

    Jun 1, 2024, 00:00

  • EPH34 Changes in the Epidemiological Burden of Breast Neoplasms in Colombia After the Cancer Control Model

    Jun 1, 2024, 00:00

  • SA40 A Targeted Literature Review of Economic Evaluations, Health-Related Quality of Life, Healthcare Resource Use, and Economic Outcomes Associated With Giant Cell Arteritis

    Jun 1, 2024, 00:00

  • CO24 Examination of the Effectiveness of a Shoulder Stabilization Programme Among Throwing Athletes

    Jun 1, 2024, 00:00

  • Psychometric Evaluation of the Patient’s Knee Implant Performance Questionnaire

    Jun 1, 2024, 00:00

  • EE253 An Evaluation of the Prevalence of Diagnosed Opioid Use Disorder and the Economic Burden of Opioid Use Disorder–Related Healthcare Costs in the United States

    Jun 1, 2024, 00:00

  • EE492 Cost-Effectiveness Analysis of the Use of Negative Pressure Wound Therapy in the Treatment of Diabetic Foot Disease in Colombia

    Jun 1, 2024, 00:00

  • P20 Cardioprotective Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Early Breast Cancer Following Anthracycline- or Trastuzumab-Based Chemotherapy

    Jun 1, 2024, 00:00

  • MSR5 Leveraging Machine Learning To Understand Pet Owner Experiences of Feline Pruritus Through Social Media Listening

    Jun 1, 2024, 00:00

  • HPR140 Are North Americans Willing-to-Pay More for Life and Limb?

    Jun 1, 2024, 00:00

  • RWD155 Real-World Treatment Patterns Among Adult Patients with Advanced Non-Small Cell Lung Cancer in the US

    Jun 1, 2024, 00:00

  • EPH77 Identifying the Characteristics of Tramadol Usage Among West Virginians

    Jun 1, 2024, 00:00

  • OP2 Health Insurance Cost Management: Perspective from the Caribbean Region, Colombia

    Jun 1, 2024, 00:00

  • EPH32 Behaviors and Characteristics of Current and Previous Users of Glucagon-like Peptide-1 Receptor Agonists (GLP-1) in an Online Health Community

    Jun 1, 2024, 00:00

  • HSD34 Analysis of Changes in the Number of Cases of Gynecological Surgeries for Benign Indications in Hungary

    Jun 1, 2024, 00:00

  • PCR32 Comparison of Quality of Life Based on Sociodemographic and Surgical Data Among Total Hip Arthroplasty Patients in Hungary

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • CO167 Type of Pre-Existing Chronic Conditions and Their Associations with Merkel Cell Carcinoma Treatment: Prediction and Interpretation Using Machine Learning Methods

    Jun 1, 2024, 00:00

  • PCR134 Psychometric Properties of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Analysis of Phase 2 CARTITUDE-2 Study Cohorts A, B, and C

    Jun 1, 2024, 00:00

  • SA53 Does Mode Matter? Impact of Survey Administration Mode on Health-Related Contingent Valuation: Face-to-Face and Telephone Interviews

    Jun 1, 2024, 00:00

  • EPH211 Treatment Patterns and Clinical Characteristics of Patients Diagnosed with Metastatic NSCLC in Hmo from Colombia: A Real Word Evidence Study

    Jun 1, 2024, 00:00

  • CO30 Comparative Genitourinary Safety of in-Class Sodium Glucose Co-Transporter-2 Inhibitors Among Patients with Heart Failure with Preserved Ejection Fraction

    Jun 1, 2024, 00:00

  • EE56 Bearing the Brunt: Disproportionate Burden Among Female Parent-Caregivers in Rare Disease

    Jun 1, 2024, 00:00

  • EPH197 Characterization of Adult Patients With Primary Chronic Immune Thrombocytopenia Using US Administrative Claims Data

    Jun 1, 2024, 00:00

  • CO127 Newer Glucose-Lowering Drugs and Risk of Suicide: A Network Meta-Analysis of Randomized Outcome Trials

    Jun 1, 2024, 00:00

  • PCR57 The Dara Project: Assessing Health and Well-Being Measures in Economically Disadvantaged Families

    Jun 1, 2024, 00:00

  • PCR138 Physiotherapy of Knee Osteoarthritis with Mechanical Traction in a Nuremberg Suspension Grid

    Jun 1, 2024, 00:00

  • EPH88 Pregnancy and Perinatal Outcomes Following Exposure to Medications for Opioid Use Disorder: An Analysis of FAERS (FDA Adverse Event Reporting System)

    Jun 1, 2024, 00:00

  • PCR234 Patient and Oncologist Preferences for Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer (ALK+ aNSCLC) Tyrosine Kinase Inhibitors (TKIs) Treatments in the First Line (1L) Setting

    Jun 1, 2024, 00:00

  • HPR2 The Use of Performance-Based Agreements in Common Diseases in EU3 and US

    Jun 1, 2024, 00:00

  • HTA1 Stakeholders Perspectives About Patient Participation in HTA in Latin America: Best Practices, Main Gaps, and Recommendations

    Jun 1, 2024, 00:00

  • EE104 Value Assessment of Emerging Treatments for Nonalcoholic Steatohepatitis: Lessons from Institute for Clinical and Economic Review Evaluations

    Jun 1, 2024, 00:00

  • CO165 Changes in Mortality Rates With the Introduction of Immuno-Oncology Therapy in Advanced Non-Small Cell Lung Cancer: A Seer-Medicare Analysis

    Jun 1, 2024, 00:00

  • EPH16 Changes in Neutropenia Outcomes Following Implementation of the Clozapine Risk Evaluation and Mitigation Strategy Update

    Jun 1, 2024, 00:00

  • PCR206 Comparison of the Measurement Properties of EQ-5D-Y-3L and CHU-9D Among Chinese High School Students with Myopia

    Jun 1, 2024, 00:00

  • SA56 Disease Severity Is Associated With Poorer Quality of Life Outcomes and Higher Costs in Thyroid Eye Disease (TED): Evidence From Systematic Literature Reviews (SLRs)

    Jun 1, 2024, 00:00

  • EE519 Economic Evaluations of Digital Health Interventions: Is Existing Guidance Being Used?

    Jun 1, 2024, 00:00

  • EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial

    Jun 1, 2024, 00:00

  • HTA31 Analyzing Indirect Treatment Comparisons in Eunethta Assessments: Lessons Learned for the Implementation of EU Joint Clinical Assessments?

    Jun 1, 2024, 00:00

  • PCR252 Assessing Treatment Preference in Pediatric Growth Hormone Deficiency: Challenges and Proposed Solutions

    Jun 1, 2024, 00:00

  • EE471 Budget Impact of Pirtobrutinib for Patients With Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the United States (US)

    Jun 1, 2024, 00:00

  • EE344 Expected Economic Savings Associated With Surgical Aortic Valve Replacement Using a Novel Tissue Bioprosthesis: An Update Based on the 7-Year Commence Trial Results

    Jun 1, 2024, 00:00

  • MSR104 Use of Stochastic Search Variable Selection for Dimension Reduction in Large NMAs

    Jun 1, 2024, 00:00

  • RWD49 Real-World Impact of Erenumab on Adherence, Work Absenteeism, and Rescue Medication Utilization Among Patients With Migraine: Results of an Outcomes-Based Agreement

    Jun 1, 2024, 00:00

  • PCR84 Urinary Incontinence and Pelvic Organ Prolapse Knowledge Among Young Women Living in Hungary

    Jun 1, 2024, 00:00

  • EPH131 Adolescent Pregnancy Before and During the SARS Cov-2 Pandemic in Cartagena De Indias, Colombia 2015 - 2021

    Jun 1, 2024, 00:00

  • EE484 Clinical and Healthcare Resource Burden of Disease in Patients With Lennox-Gastaut Syndrome (LGS): Results From a US Claims Matched-Control Analysis

    Jun 1, 2024, 00:00

  • PCR87 Supporting Diversity and Inclusion Through the Evaluation of Differential Item Functioning (DIF) By Race and Ethnicity in the Asthma Control Questionnaire and Asthma Quality of Life Questionnaire Using Dupilumab Phase 3 Data

    Jun 1, 2024, 00:00

  • RWD81 Economic Impact of Epilepsy in Private Healthcare in Brazil

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective

    Jun 1, 2024, 00:00

  • EE45 Influential Factors on the Economic Justifiable Pri Systematic Investigation of Factors and Mechanisms Beyond the Incremental Cost Effectiveness Ratio

    Jun 1, 2024, 00:00

  • MSR17 Leveraging Large Language Models (LLMs) for Classifying Peer Reviewed Publications for Literature Review

    Jun 1, 2024, 00:00

  • RWD31 Racial Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplant in US: A Real-World Data Study

    Jun 1, 2024, 00:00

  • RWD119 A Methodological Approach Using Sentiment Analysis of Online Medical Platforms As a Real-World Data Source of Patient Experiences

    Jun 1, 2024, 00:00

  • SA76 A Targeted Literature Review of Economic Evaluations, Health-Related Quality of Life, Healthcare Resource Use, and Costs Associated With Polymyalgia Rheumatica

    Jun 1, 2024, 00:00

  • CO118 Sickle Cell Disease Outcomes in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR240 Medication Adherence to Direct Acting Anti-Viral Agents Among Hepatitis C Virus Infected Patients in the United States

    Jun 1, 2024, 00:00

  • HSD49 U.S. Real-World Biosimilar Adoption By Specialty Therapeutic Area

    Jun 1, 2024, 00:00

  • MSR23 Optimizing Regression Models for Patient-Level Utility Scores: A Case Study on Addressing Ceiling Effects in EQ-5D Data from the MYR301 Clinical Trial

    Jun 1, 2024, 00:00

  • HPR149 Americans' Views on Health Inequality in the United States: Results from a General Population Survey

    Jun 1, 2024, 00:00

  • CO129 Novel Endpoints in Chronic Kidney Disease (CKD): Trends in the Use of eGFR Slope and Proteinuria As Efficacy Endpoints in Clinical Trials

    Jun 1, 2024, 00:00

  • PCR152 Can We Speak to GPT to Inform Patient Preference Studies?

    Jun 1, 2024, 00:00

  • EE41 Economic Evaluation for the United States (US) of the Overall Survival Analysis of Cemiplimab Plus Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer (NSCLC) With at Least 50% PD-L1 Positivity

    Jun 1, 2024, 00:00

  • RWD61 Characterization of SLE Patient Population from the FORWARD Lupus Registry (FLR) in the US

    Jun 1, 2024, 00:00

  • P16 Generalized Prevalence-Adjusted Willingness-to-Pay to Control for Health Equity in Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan

    Jun 1, 2024, 00:00

  • HPR73 Breast Cancer-Related Healthcare Resource Utilization and Staging before and after the COVID-19 Pandemic Among White and Black Patients with Newly Diagnosed Breast Cancer

    Jun 1, 2024, 00:00

  • CO14 Profiling Adverse Events in Multiple Myeloma: Insights from Clinical Trials Via Large Language Models

    Jun 1, 2024, 00:00

  • SA34 Cost-Effectiveness Analysis of the Use of Negative Pressure Wound Therapy in the Treatment of Diabetic Foot Disease - A Systematic Literature Review

    Jun 1, 2024, 00:00

  • SA13 Approaches to Electronic Health Records Notes Selection: Considerations for Best Practices

    Jun 1, 2024, 00:00

  • EE236 Healthcare Resource Utilization (HCRU) and Direct Medical Costs Following Acute SARS-Cov-2 Infection: Findings From a Literature Review

    Jun 1, 2024, 00:00

  • RWD116 Navigating the Currents of the Pandemic: A Comprehensive Analysis of Medicare Data Reflecting COVID-19's Impact on Cardiovascular Disease Healthcare Utilization

    Jun 1, 2024, 00:00

  • PCR93 Assessment of Prior Experience With Pharmacists and Perceptions of Pharmacists’ Education and Training on Metabolic Syndrome (MetS) Patients’ Willingness to Accept Pharmacist-Provided Services

    Jun 1, 2024, 00:00

  • EE460 Theoretical Exploration of the Inclusion of Non-Traditional Multiple Sclerosis Measurement Variables on the Cost-Effectiveness of Future Treatments

    Jun 1, 2024, 00:00

  • EE401 Unlocking the Economic Potential of Digital Health Interventions in Cardiovascular and Metabolic Diseases

    Jun 1, 2024, 00:00

  • EPH235 Impact of Real-Time Containment Measures on COVID-19 Pandemic Outcomes in African Countries

    Jun 1, 2024, 00:00

  • RWD138 Evidence Gap Analysis of the Burden of Illness and Treatment of Myasthenia Gravis

    Jun 1, 2024, 00:00

  • HPR126 Monitoring Drug Volume-Based Procurement in Shanghai, China: A Data-Driven Situation Analysis

    Jun 1, 2024, 00:00

  • CO5 Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation From SEER-Medicare Database

    Jun 1, 2024, 00:00

  • CO65 Overall Survival in Metastatic NSCLC in HMO From Colombia: A Non-Interventional Study

    Jun 1, 2024, 00:00

  • SA65 Healthcare Resource Utilization Following 6 Months of Treatment With Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia or Bipolar I Disorder

    Jun 1, 2024, 00:00

  • MSR89 Machine Learning-Based Approach to Discover Subtypes of Light-Chain Amyloidosis Using US Claims Data

    Jun 1, 2024, 00:00

  • MSR51 Evaluation of Machine Learning Approaches in Predicting the Initial Treatment Strategy in Patients with Multiple Sclerosis

    Jun 1, 2024, 00:00

  • EE408 Healthcare Costs Among Patients Diagnosed With Estrogen Receptor Positive (ER+) Breast Cancer: Relationship With Comorbid Depression and Adherence to Anti-Depressant Medication

    Jun 1, 2024, 00:00

  • EE388 Economic Evaluation and Budget Impact of Brigatinib Versus Other ALK-Inhibitors for First-Line ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Treatment in the Brazilian Private Healthcare System

    Jun 1, 2024, 00:00

  • PCR106 Willingness To Pay for Temporary Alleviation of Anemia Status Transfusion-Dependent Beta-Thalassemia Patients in China

    Jun 1, 2024, 00:00

  • RWD141 Assessing the Potential Value of the Flatiron Health Commercial Mortality Data Combined with Publicly Available Death Data for Non-Oncology Research

    Jun 1, 2024, 00:00

  • EE281 Cost-Effectiveness of Every Two Month Cabotegravir Long-Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Compared with Daily Oral Tenofovir Disoproxil Fumarate (TDF)/ Emtricitabine (FTC) As Prep to Prevent HIV-1 in the UK

    Jun 1, 2024, 00:00

  • HTA62 Understanding the Disconnect: Characterizing Trends in Inclusion of Family and Informal Caregiver Spillover in US Value Assessments

    Jun 1, 2024, 00:00

  • EE173 Exploring the Financial Burden Associated with the Management of Dystrophic Epidermolysis Bullosa (DEB): A Systematic Literature Review (SLR) with Database Review of Future Disease-Modifying Therapies (DMTs)

    Jun 1, 2024, 00:00

  • RWD124 Validation of Treatment Patterns in Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States Using Administrative Claims Datasets

    Jun 1, 2024, 00:00

  • PCR214 Patients’ Preference and the Influencing Factors of Treatment Compliance in Chinese Patients With Maculopathy: A Qualitative Interview Research

    Jun 1, 2024, 00:00

  • Healthcare Resource Utilization and Cost Burden of Selected Chronic Conditions

    Jun 1, 2024, 00:00

  • PCR231 Changes in Health-Related Quality of Life in Vivax Malaria Patients: Measurement and Valuation in Indonesia and Cambodia

    Jun 1, 2024, 00:00

  • RWD12 Potentially Modifiable Risk Factors for Alzheimer Disease in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE269 Direct Medical Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Colombia

    Jun 1, 2024, 00:00

  • MT46 Patient Experience and Outcomes with Post-Surgical Remote Monitoring for Patients with Total Knee Arthroplasty (TKA)

    Jun 1, 2024, 00:00

  • EE238 The Budget Impact of Establishing a County-Level Cancer Prevention and Care Center in China

    Jun 1, 2024, 00:00

  • MT29 Budget-Impact of Implementing an Outpatient Heart Failure Management System Following Diagnosis of Heart Failure

    Jun 1, 2024, 00:00

  • EE47 Cost Per Recurrence-Free Survivor (CPRS) and Cost Per Recurrence-Free Life Month (CPRLM) of Adjuvant Nivolumab (NIVO) Versus Pembrolizumab (PEMBRO) Among Patients With Resected Stage IIB/IIC Melanoma

    Jun 1, 2024, 00:00

  • PT23 Is a Large Language Model (LLM) More Accurate Than Human Researchers in Correctly Identifying Diseases in Biomedical Abstracts? A Pilot Study

    Jun 1, 2024, 00:00

  • HSD119 Unveiling Priority Challenges in the Healthcare System for Ovarian Cancer: Advancement and Plausible Solutions

    Jun 1, 2024, 00:00

  • Author Reply

    Jun 1, 2024, 00:00

  • EPH72 Mortality From Diabetes Mellitus in the Department of Bolívar, Colombia: A 5-Year Analysis

    Jun 1, 2024, 00:00

  • RWD89 Healthcare Resource Utilization and Health-Related Quality of Life in Patients With Resectable Non-Metastatic Non-Small Cell Lung Cancer Treated With Neoadjuvant Chemotherapy in China: A Real-World Survey

    Jun 1, 2024, 00:00

  • EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis

    Jun 1, 2024, 00:00

  • HTA41 Analysis of Intensity of Use of Real-World Data in Single Technology Appraisals of Cancer Drugs By the National Institute for Health and Care Excellence

    Jun 1, 2024, 00:00

  • HSD107 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries by Sex, Age, and Race/Ethnicity

    Jun 1, 2024, 00:00

  • EPH217 Annual Epidemiological and Health Insurance Disease Burden of Endometriosis in Hungary Based on Real-World Health Insurance Claims Data

    Jun 1, 2024, 00:00

  • CO130 Diagnosis, Treatment, and Control of Hypertension Among US Adults: The National Health and Nutrition Examination Survey, 2009 to 2020

    Jun 1, 2024, 00:00

  • EE122 Analyses of Cancer Prevalence and Healthcare Costs for Metastatic and Non-Metastatic Cancers Among Employees Using Claims Data

    Jun 1, 2024, 00:00

  • EE165 A Cost-Consequence Analysis of Ponatinib Versus Imatinib in Patients with Newly Diagnosed Philadelphia-Positive Acute Lymphoblastic Leukemia in the United States

    Jun 1, 2024, 00:00

  • MSR81 Quantitative Assessment of Effect Modifiers in NMA - Leveraging Subgroup Data

    Jun 1, 2024, 00:00

  • EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity Loss

    Jun 1, 2024, 00:00

  • Assessing the Performance of Alternative Methods for Estimating Long-Term Survival Benefit of Immuno-oncology Therapies

    Jun 1, 2024, 00:00

  • HSD35 Real-World Treatment Patterns and Treatment Sequences in the Metastatic Castration-Resistant Prostate Cancer Settings across Europe

    Jun 1, 2024, 00:00

  • Multidimensional Thresholding for Individual-Level Preference Elicitation

    Jun 1, 2024, 00:00

  • PCR125 Measuring and Valuing Health for Children: A Series of Reviews to Inform Health Technology Assessment

    Jun 1, 2024, 00:00

  • PCR191 Patient-Centric Assessment of Treatment Experience in Breast Cancer: Development and Validation of a Patient Questionnaire

    Jun 1, 2024, 00:00

  • EPH184 Patient Journey of Head Neck Squamous Cell Cancer in Oncology Centers in Colombia

    Jun 1, 2024, 00:00

  • HTA35 Selection of Appropriate Endpoints for the EU JCA and National Assessments in Select Member States and England for ATMPs

    Jun 1, 2024, 00:00

  • CO20 Treatment Regimens and Persistence in Colombian Patients Diagnosed With Rheumatologic Diseases After Failure of Conventional Disease-Modifying Antirheumatic Drugs

    Jun 1, 2024, 00:00

  • EPH98 Association Between Social Vulnerability and Opioid Dispensing By Contiguous County in the United States

    Jun 1, 2024, 00:00

  • EPH202 Assessing Trends in Utilization and Off-Label Prescribing for Ozempic, a Glucagon-like Peptide Receptor Agonist

    Jun 1, 2024, 00:00

  • EE53 A Cost of Illness Analysis of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) With FLT3 Mutations in Chile: A Public Payer Perspective

    Jun 1, 2024, 00:00

  • EPH101 Estimating Total Number of Influenza Cases From Reported Hospitalizations: A Multi-Country Comparison of the Multiplier Method

    Jun 1, 2024, 00:00

  • EPH214 Impact of Preoperative Anxiety and Depression on Chronic Postoperative Opioid Use in Orthopedic Surgery Patients

    Jun 1, 2024, 00:00

  • RWD77 Time to Reimbursement in Kazakhstan for Novel Biologic Medicines Approved during the Period 2013-2022

    Jun 1, 2024, 00:00

  • EPH170 The Net Environmental Impact of Preventative Healthcare - Vaccination's Potential in the Fight Against Climate Change

    Jun 1, 2024, 00:00

  • PCR21 The Impact of Fathers' Supportive Role, Mood State Changes on Long-Term Breastfeeding in the Postpartum Period

    Jun 1, 2024, 00:00

  • EPH58 Changes in the Number of Different Categories of Specialists in Europe

    Jun 1, 2024, 00:00

  • EE172 Quantifying the Relationship between Time to Diagnosis and Potential System Level Burden in Obstructive Hypertrophic Cardiomyopathy (HCM)

    Jun 1, 2024, 00:00

  • EPH191 Age-Related Trends of Blood Glucose, Hyperglycemia, and Type 2 Diabetes in Youth Prescribed Second-Generation Antipsychotic Medications

    Jun 1, 2024, 00:00

  • HPR99 Medicare Drug Price Negotiation: The Complexities of Selecting Therapeutic Alternatives for Estimating Comparative Effectiveness

    Jun 1, 2024, 00:00

  • CO37 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Clinical Outcomes of Patients with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) in Alberta, Canada

    Jun 1, 2024, 00:00

  • HTA57 Uptake of Early Health Technology Assessment in the United States (US): A Literature Review of Empirical Studies

    Jun 1, 2024, 00:00

  • CO10 Early Adoption and Utilization of Perfluorohexyloctane for Treatment of Dry Eye Disease

    Jun 1, 2024, 00:00

  • PT19 Developing a Bespoke Neural Network Model for Diagnosing Alzheimer's Dementia: A Fit-for-Purpose Machine Learning Study

    Jun 1, 2024, 00:00

  • EPH67 Incidence of Mortality and the Impact of Malnutrition on Chronic Kidney Disease Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • CO53 Real-World Evidence of the Effectiveness of Inhaled Corticosteroid-Containing Therapies in Reducing Exacerbations and Medical Costs in COPD

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • MT40 Budget Impact of Implementing an Advanced Interventional Suite Platform for Interventional Procedures

    Jun 1, 2024, 00:00

  • PCR139 Beneficial Effect of Physical Activity on Pain-Related Self-Efficacy Among Women with Endometriosis and Chronic Pelvic Pain, Cross-Sectional Study

    Jun 1, 2024, 00:00

  • HSD29 Predicting Psoriasis Area and Severity Index From Physician Global Assessment and Body Surface Area in the Real-World Dermatology Setting

    Jun 1, 2024, 00:00

  • CO110 Physical Examination of the Functional Status of the Hip and Spine in Junior Swimmers and Synchronised Swimmers

    Jun 1, 2024, 00:00

  • HPR20 Comparison of Biosimilar Reimbursement Policies in the US and Select European Markets

    Jun 1, 2024, 00:00

  • HTA78 Strategic Roadmap for Successful Market Penetration in the Dynamic Central and Eastern Europe: Prospect for US/Global Companies?

    Jun 1, 2024, 00:00

  • P6 The Effect of Formulary Restrictions on the Disease Outcomes Among Medicare Beneficiaries With Multiple Sclerosis in the United States

    Jun 1, 2024, 00:00

  • HPR87 Assessing the Implementability of Regulatory Agencies’ Guidance on Diversity in Clinical Trials

    Jun 1, 2024, 00:00

  • HPR93 Price Evolution of Selected Cancer Immunotherapies in the US and Key European Markets

    Jun 1, 2024, 00:00

  • PT10 Utility of the ISPOR Presentations Database to Support the Centers for Medicare and Medicaid Services (CMS) Drug Price Negotiation (DPN): An Apixaban and Rivaroxaban Case Study

    Jun 1, 2024, 00:00

  • EE357 Using a Computer Vision-Based System for Reading Skin Prick Test Results: A Cost-Minimisation Analysis

    Jun 1, 2024, 00:00

  • PCR40 Evaluating the Evolution of Patient-Reported Outcome Measures (PROMs) in Health Technology Assessments: A Focus on Neurological Diseases in NICE Technology Appraisals

    Jun 1, 2024, 00:00

  • HTA16 A Preliminary Assessment of ICER's New HTA Methods That Support Health Equity

    Jun 1, 2024, 00:00

  • HPR142 Review of Gene Therapy Access Landscape

    Jun 1, 2024, 00:00

  • EE359 Economic Burden of Managing Acute and Chronic Pain in the United States: National Estimates from 2022 Data

    Jun 1, 2024, 00:00

  • RWD82 Treatment Patterns of Ulcerative Colitis and Crohn's Disease Patients in Taiwan: A National Health Insurance Research Database (NHIRD) Study

    Jun 1, 2024, 00:00

  • RWD113 Comparative Analysis of Vaping Use Disorder (VUD) and CDC Proxy Codes: A Demographic Perspective

    Jun 1, 2024, 00:00

  • CO185 Efficacy and Safety of Traditional Chinese Medicine for Acute Ischemic Stroke: A Systematic Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • EE64 Treatment-Related Costs of Ponatinib and Asciminib in Adults Patients with T315I-Positive Chronic Phase Chronic Myeloid Leukemia with Resistance or Intolerance to at Least Two Prior Kinase Inhibitors in the United States

    Jun 1, 2024, 00:00

  • EPH4 Assessing the Association Between Body Mass Index, Cholesterol, and Cancer Among United States Adults in the Medical Expenditure Panel Survey Using a Cross-Sectional Design

    Jun 1, 2024, 00:00

  • HTA53 Advances in Science and Challenges at HTA: The Case of CRISPR Technologies

    Jun 1, 2024, 00:00

  • EE371 Treatment Patterns, Healthcare Resource Use, and Costs Among US Patients With Epidermal Growth Factor Receptor Mutated (EGFRm) Metastatic Non-Small Cell Lung Cancer (mNSCLC) After Discontinuation of Osimertinib

    Jun 1, 2024, 00:00

  • PCR151 Understanding the Patient Perspectives of Post-Discharge Care and Impact of Treatment in the First Year Post-Acute Myocardial Infarction

    Jun 1, 2024, 00:00

  • EPH177 Clinical and Sociodemographic Characteristics of Patients With Vitiligo in Colombia: Preliminary Results From REVIC

    Jun 1, 2024, 00:00

  • EE476 Cost of COVID-19 Vaccine Delivery Integration into Routine Immunization and Service Delivery in South Africa

    Jun 1, 2024, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • »